Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Retirement Systems of Alabama

Retirement Systems of Alabama decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 175,602 shares of the medical equipment provider's stock after selling 1,605 shares during the period. Retirement Systems of Alabama's holdings in Intuitive Surgical were worth $86,970,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Vanguard Group Inc. grew its stake in shares of Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after purchasing an additional 360,591 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Intuitive Surgical by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock worth $4,039,200,000 after acquiring an additional 243,802 shares in the last quarter. Fisher Asset Management LLC boosted its position in shares of Intuitive Surgical by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock worth $2,541,356,000 after acquiring an additional 86,488 shares in the last quarter. Norges Bank acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $2,401,493,000. Finally, Invesco Ltd. boosted its position in shares of Intuitive Surgical by 7.7% during the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock worth $2,165,184,000 after acquiring an additional 295,025 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Royal Bank Of Canada lowered their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Barclays decreased their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Finally, Robert W. Baird decreased their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $588.95.

Insider Transactions at Intuitive Surgical

In other news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Gary Loeb sold 1,700 shares of the stock in a transaction that occurred on Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the sale, the executive vice president now directly owns 2,245 shares of the company's stock, valued at $1,152,089.10. This trade represents a 43.09% decrease in their position. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock valued at $2,611,577 over the last 90 days. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Down 0.0%

Shares of ISRG stock traded down $0.13 on Friday, reaching $509.36. 2,827,555 shares of the stock were exchanged, compared to its average volume of 1,682,020. The stock has a market cap of $182.56 billion, a P/E ratio of 74.69, a price-to-earnings-growth ratio of 5.40 and a beta of 1.67. The firm has a 50 day moving average of $528.03 and a two-hundred day moving average of $537.47. Intuitive Surgical, Inc. has a 1-year low of $413.82 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same period in the prior year, the firm posted $1.50 earnings per share. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.